Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial

PRODUCT LITERATURE

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial

Henry RR - Personal Name;

Combining metformin (XR) with dapagliflozin to initiate pharmacotherapy in patients with type 2 diabetes (T2D) and high baseline HbA1c may be advantageous. We conducted two randomised, double-blind, three-arm 24-week trials in treatment-naı¨ve patients to compare dapagliflozin plus metformin, dapagliflozin alone and metformin alone.

Availability

Location name is not set Location name is not set

Dafoxa-005

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: TEXTBOOK
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Type 2 Diabetes
Dafoxa
Dapagliflozin
Specific Detail Info: -
Statement of Responsibility: Int J Clin Pract, May 2012, 66, 5, 446–456

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment